Source: http://healthlawreporter.bbablogs.org/page/4/
Timestamp: 2019-04-26 02:10:37+00:00

Document:
Health Law Case Brief: Conrad v. Abbott Laboratories, Inc.
Jeffrey Hoffmann is a student at Boston University School of Law concentrating in health law. He earned his B.A. from Columbia University, during which he worked at the U.S. Senate, Brooklyn District Attorney’s Office, and Manhattan Attorney General’s Office. He has since been a paralegal at Willkie Farr & Gallagher in New York City and has worked as a legal intern for Common Cause Massachusetts and the Joslin Diabetes Center. Mr. Hoffmann is currently a member of the American Journal of Law and Medicine for which he will serve as Note Editor in the coming year.
[i] 31 U.S.C. § 3729; U.S. ex rel. Conrad v. Abbott Labs. Inc., No. 02-11738-RWZ, 2013 WL 682740, at *1 (D. Mass. Feb. 25, 2013).
[ii] Conrad, 2013 WL 682740, at *1.
[iv] Conrad, 2013 WL 682740, at *2-3.
[vi] Conrad, 2013 WL 682740, at *3-4.
[vii] Conrad, 2013 WL 682740, at *4-5 [citing United States ex rel. Poteet v. Bahler Medical, Inc., 619 F.3d 104, 109 (1st Cir. 2010; and also United States ex rel. Ondis v. City of Woonsocket, 587 F. 3d. 49, 54 (1st Cir. 2009).
[xv] Id. at *6 (citing U.S. ex rel. Ondis v. City of Woonsocket, 587 F.3d 49, 58 (1st Cir. 2009)).
[xvi] Conrad, 2013 WL 682740, at *6.

References: v. 
 § 3729
 v. 
 v. 
 v. 
 v.